SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-22-024579
Filing Date
2022-02-01
Accepted
2022-02-01 16:06:52
Documents
2
Group Members
SUMITOMO DAINIPPON PHARMA CO., LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13G d285370dsc13g.htm SC 13G 51986
2 EX-99.1 d285370dex991.htm EX-99.1 4918
  Complete submission text file 0001193125-22-024579.txt   58470
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Subject) CIK: 0001635088 (see all company filings)

IRS No.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: SC 13G | Act: 34 | File No.: 005-93291 | Film No.: 22578959
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7-1, NIHONBASHI 2-CHOME CHUO-KU TOKYO M0 103-6020
Business Address 7-1, NIHONBASHI 2-CHOME CHUO-KU TOKYO M0 103-6020 813-5201-0222
Sumitomo Chemical Co., Ltd. (Filed by) CIK: 0001798550 (see all company filings)

IRS No.: 980339148 | State of Incorp.: M0 | Fiscal Year End: 0331
Type: SC 13G